Review Papers Against Their Own Results

 Quick Answer Copied

 Long Answer

Core Findings

The authors determined three high-resolution (1.97–1.98 Å) co-crystal structures of EV68-3C protease bound to rupintrivir (PDB 8W3C), AG7404 (8W3M), and GC-376 (8W3T), all in space group P3₁21 with clear electron density for full inhibitors EV68-3C inhibitor co-crystal structures. Enzymatic assays showed rupintrivir most potent (IC50 0.0078 µM), followed by AG7404 (0.0235 µM), GC-376 (0.194 µM), and PF-00835231 (1.8 µM); nirmatrelvir and ensitrelvir showed no inhibition even at 10 µM — a notable negative result given nirmatrelvir's nanomolar potency against SARS-CoV-2 Mpro, attributed to the bulky bicyclic proline at P2 Enzymatic IC50 panel against EV68-3C.

Novel Structural Observations

Three findings stand out: (1) the catalytic His40 adopts three distinct conformations across co-crystals solved under identical crystallization conditions, contradicting the prior attribution of His40 conformers to pH differences His40 conformational flexibility finding; (2) a structural water molecule capping the S1 pocket (coordinating Thr142, Asn165, Gly166, Gln168) appears in all ligand-bound EV68-3C structures and homologous enterovirus 3C structures, but is absent in apo structures — a conserved, targetable feature Conserved S1 pocket structural water; (3) substrate-envelope analysis predicts resistance-vulnerable protrusions at S1 (Gly166/Ala144), S2/S3 (Gly128), and S4 (Asn165), with GC-376 predicted to have a higher resistance barrier than rupintrivir or AG7404 Substrate envelope resistance predictions.

Critical Assessment

The structural work is rigorous (Rfree 0.23–0.24, zero Ramachandran outliers, His-tag packing verified not to perturb active-site binding via comparison with tag-free 7L8H) Refinement quality and packing control. However, several limits warrant skepticism: resistance predictions rest entirely on crystallographic envelope inference — no reverse genetics or resistance-selection experiments in replicating virus were performed; nirmatrelvir's failure to inhibit despite MD-predicted stability reveals a disconnect between the authors' computational prescreen and experiment, undermining confidence in MD-based inhibitor selection; and the "higher resistance barrier" ranking of GC-376 is a hypothesis, not a measured quantity. The in vitro FRET assay uses a single substrate (2C/3A site), and cell-based antiviral or pharmacokinetic data are absent, so potency-to-therapeutic translation remains unestablished. The claimed conflict-free status and lack of listed funding leave provenance transparent but funding sources unstated.

Interactive view: rupintrivir-bound EV68-3C protease (PDB 8W3C).

Explore Further

Author Reviews

 BGPT Paper Review

Study Novelty

Applies the established Schiffer-lab substrate-envelope framework (previously demonstrated for HIV-1, HCV, SARS-CoV-2) to a new target; the His40-flexibility-under-identical-conditions and conserved S1 water observations are genuinely new, but the methodological playbook is well-trodden.

Scientific Quality

High-quality crystallography with proper controls (Rfree, packing verification against tag-free construct, triplicate IC50 assays, negative controls). Red flags: MD prescreen mispredicted nirmatrelvir, resistance predictions unvalidated experimentally, funding not disclosed despite the declaration statement.

Study Generality

Findings on the conserved S1 water and His40 flexibility generalize across picornavirus 3C proteases (supported by cross-viral PDB comparison), but quantitative potency and resistance conclusions are EV68-specific.

Study Usefulness

Directly actionable for medicinal chemists designing EV68 or pan-enteroviral 3C inhibitors; identifies specific residues and design strategies (P1 water-mimicry, P1' expansion behind flexible His40) with no approved antiviral currently available for EV68.

Study Reproducibility

Deposited PDB structures (8W3C/M/T), detailed expression/crystallization protocols, beamline specified, and scripts on GitHub; in vitro assays use commercially available reagents. Missing: raw assay data and exact replicates handling beyond stated triplicates.

Explanatory Depth

Mechanistic explanations (P2 chemistry → His40 conformation; water coordination network; envelope protrusion → mutation sites) are structurally grounded but lack thermodynamic quantification or kinetic validation linking observed features to binding free energy.